The top emerging pharmaceutical companies in the US
While big pharma holds a sizable stake in the healthcare sector, several biotechs and mid-sized pharma companies fuel both the…
All articles by Irena Maragkou
Irena Maragkou
Irena Maragkou is a Healthcare Researcher for Clinical Trials Arena and Pharmaceutical Technology based in London, UK. Irena previously worked in consulting at Deloitte’s Strategy, M&A and Analytics Department, focusing on projects in the Pharmaceutical and Healthcare Sector. She holds an MSci degree in Neuroscience from UCL.
-
-
Delivery and manufacturing hurdles remain in the cell and gene therapy
The current prospects and obstacles in the cell and gene therapy space were the key focus of a panel at…
-
Delivery tech remains challenging with gene therapies for brain disorders
While the science behind specialised gene therapies continues to develop at a rapid rate, in neurodegenerative conditions the profound lack…
-
What’s next for AAV gene therapies in 2024?
Numerous FDA approvals of cell and gene therapies rendered 2023 as a landmark year for the gene therapy space. With…
-
Biotechs ride obesity drug wave with novel approaches that go beyond GLP-1RAs
The 2021 US approval of Novo Nordisk’s breakthrough therapy Wegovy (semaglutide) for obesity transformed the disease landscape, prompting companies to…
-
Quality and sustainability: The balancing act for pharma manufacturing
Trends in sustainability and quality assurance were key themes discussed amongst panelists at Convention on Pharmaceutical Ingredients (CPHI) Europe 2023,…
-
The future of cell and gene therapy manufacturing
The global pharmaceutical industry finds itself at a compelling intersection. The next five years will signify a critical period with…
-
Are haemophilia gene therapies truly “one and done”?
New innovative therapies are changing the treatment landscape for haemophilia, but experts say the endorsement of cheaper treatments without addressing…
-
CPHI Europe: Taking the lessons of Covid-19 to the next frontier
The pharmaceutical industry is more prepared for a future pandemic following Covid-19, said Nicolas Chornet, senior Vice President International Manufacturing,…
-
CPHI Europe: Pharma companies fail to engage patients early in drug development
The pharma industry is now incorporating more patients’ perspectives in the development process of their products, but there is still…